Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant

References

• Egli A, Infanti L, Dumoulin A, et al Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009;199:837–846.
   PubMed Web of Science ®Google Scholar
• Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009;5:e1000363.
   PubMed Web of Science ®Google Scholar
• Leung AYH, Yuen K, Kwong Y. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005;36:929–937.
   PubMed Web of Science ®Google Scholar
• Giraud G, Bogdanovic G, Priftakis P, et al The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006;91:401–404.
   PubMed Web of Science ®Google Scholar
• Tsuboi K, Kishi K, Ohmachi K, et al Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:903–907.
   PubMed Web of Science ®Google Scholar
• Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006;81:535–537.
   PubMed Web of Science ®Google Scholar
• Garderet L, Bittencourt H, Sebe P, et al Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 2000;70:1807–1811.
   PubMed Web of Science ®Google Scholar
• Laszlo D, Bosi A, Guidi S, et al Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica 1995;80:421–425.
   PubMed Web of Science ®Google Scholar
• Purves JT, Graham ML, Ramakumar S. Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis. Urology 2005;66:641–643.
   PubMed Web of Science ®Google Scholar
• Lache M, Jacob F, Schmitt A, et al Levofloxacin prophylaxis decreases the incidence of BK polyomavirus-induced haemorrhagic cystitis in patients after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008;45(Suppl. 2):227.
   Google Scholar
• Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 2006;8:86–94.
   PubMed Web of Science ®Google Scholar
• Binggeli S, Egli A, Schaub S, et al Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007;7:1131–1139.
   PubMed Web of Science ®Google Scholar
• Chen Y, Trofe J, Gordon J, Autissier P, Woodle ES, Koralnik IJ. BKV and JCV large T antigen-specific CD8 + T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008;42:198–202.
   PubMed Web of Science ®Google Scholar
• Chen Y, Trofe J, Gordon J, et al Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006;80:3495–3505.
   PubMed Web of Science ®Google Scholar
• Krymskaya L, Sharma MC, Martinez J, et al Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005;79:11170–11178.
   PubMed Web of Science ®Google Scholar
• Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994;152:163–175.
   PubMed Web of Science ®Google Scholar
• Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanović S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999;50:213–219.
   PubMed Web of Science ®Google Scholar
• Wong ASY, Cheng VCC, Yuen K-Y, Kwong Y-L, Leung AYH. High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis. Bone Marrow Transplant 2009;43:43–47.
   PubMed Web of Science ®Google Scholar
• Lima MA, Marzocchetti A, Autissier P, et al Frequency and phenotype of JC virus-specific CD8 + T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 2007;81:3361–3368.
   PubMed Web of Science ®Google Scholar
• Schmitt A, Tonn T, Busch DH, et al Adoptive transfer and consequential selective reconstitution of streptamer-selected cytomegalovirus-specific CD8 + T cells leads to enduring virus clearance in patients after allogeneic stem cell transplantation. Blood 2008;112(Suppl. 1): 1181.
   Google Scholar
• Fujita Y, Rooney CM, Heslop HE. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant 2008;41:193–198.
   PubMed Web of Science ®Google Scholar
• Greiner J, Li L, Ringhoffer M, et al Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8 + T cells of HLA-A2-positive patients with acute myeloid leukemia. Blood 2005;106:938–945.
   PubMed Web of Science ®Google Scholar
• Li J, Melenhorst J, Hensel N, et al T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J Gen Virol 2006;87:2951–2960.
   PubMed Web of Science ®Google Scholar
• Sharma MC, Zhou W, Martinez J, et al Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Virology 2006;350:128–136.
   PubMed Web of Science ®Google Scholar